Severin Schwan

Last updated
Severin Schwan
Severin Schwan (2012).png
Schwan in 2012
Born
Severin Anton Schwan

(1967-11-17) November 17, 1967 (age 56)
Hall in Tirol, Austria
Citizenship
  • Austria
  • Germany
  • Switzerland (from 2020)
Education
Title Chairman of the Board of Roche Group
Spouse
Ingeborg Stix
​
(m. 1995)​
Children3

Severin Anton Schwan (born November 17, 1967) is the current chairman of the board and previously was CEO of the Roche Group. He was the CEO between 2008 and 2023. He joined in 1993 as a trainee and has stayed with the company ever since. [1] [2]

Contents

Early life

Severin Schwan graduated from the Akademisches Gymnasium Innsbruck and then studied economics at the University of Innsbruck, University of York and University of Oxford as well as law at the University of Innsbruck. [3] He completed both subjects in 1991 with a master's degree and acquired the title Mag. iur. and Mag. rer. soc. oec. After obtaining his Doctorate in Law in 1993, he has held various positions within the Roche Group. [4]

Career

Schwan started his career as a trainee at the Roche office in Basel. He has worked in a number of positions across the globe for Roche. He was appointed CEO of the Roche Group at its Annual General Meeting on March 4, 2008, replacing Franz B. Humor. [5] Previously, Schwan was managing director of Roche's Diagnostics Division.

He has been a member of the Board of Directors of Roche Holding AG since 2013. At the Annual General Meeting on March 14, 2023, he was elected chairman of the Board of Directors, succeeding Christoph Franz. [6] Thomas Schinecker became Schwan's successor as CEO. [7]

From 2014 to 2022, he was a member of the board of directors of Credit Suisse, and from 2017 its vice chairman. He stepped down from the position of vice-chair in March 2022. [8] [9]

Memberships

He was on the board at Chugai Pharmaceutical Co., Ltd. Schwan has been a member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC) since 2009 and Vice President since 2022. [10]

From 2016 to 2020, he was Vice President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). [11]

Personal life

Born to an Austrian-German family, Schwan is citizen of both countries. He was also granted Swiss citizenship in 2020. [12] [13] Schwan is married, has three children and lives in the Basel suburb of Riehen. [14] [15]

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical Research and Manufacturers of America</span> Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.

<span class="mw-page-title-main">Peter Brabeck-Letmathe</span>

Peter Brabeck-Letmathe is an Austrian businessman. He is the chairman emeritus, former chairman and CEO of the Nestlé Group, and former chairman of Formula One.

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents internationally over 90 leading innovative pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions.

Raymond V. Gilmartin is an American former business executive and an adjunct professor of management practice at the Harvard Business School.

<span class="mw-page-title-main">National Space Council</span> Presidential advisory body focused on US space policy

The National Space Council is a body within the Executive Office of the President of the United States created in 1989 during the George H. W. Bush administration, disbanded in 1993, and reestablished in June 2017 by the Donald Trump administration. It is a modified version of the earlier National Aeronautics and Space Council (1958–1973).

<span class="mw-page-title-main">Christoph Franz</span> Swiss-German businessman

Christoph Franz is a German engineer and manager who served as chief executive officer of Lufthansa from 2011 until 2014.

Gregory David Wasson is an American businessman. He is the co-founder and president of Wasson Enterprise, a family-based investment office, the executive chairman of Innventure, co-founder of CoolerScreens, and the former president and chief executive officer (CEO) of Walgreens Boots Alliance (NASDAQ:WBA).

<span class="mw-page-title-main">Ulrich Körner</span> German-Swiss business person (born 1962)

Ulrich Körner is a German-Swiss businessman. In March 2021, he was named CEO Asset Management of Credit Suisse until July 2022, when he was appointed CEO of Credit Suisse AG.

<span class="mw-page-title-main">Ajay Banga</span> American business executive (born 1959)

Ajaypal Singh "Ajay" Banga is an Indian-born American business executive. He is currently the president of the World Bank Group. He was vice chairman at General Atlantic, and was before that executive chairman of Mastercard, after having previously served as president and chief executive officer (CEO) of the company from July 2010 until December 31, 2020. He retired from this position on December 31, 2021, to join General Atlantic. He is also the chairman of Netherlands-based investment holding company Exor and chairman of the public-private Partnership for Central America with U.S. Vice President Kamala Harris.

<span class="mw-page-title-main">Alex Gorsky</span> American businessman (born 1960)

Alex Gorsky is an American businessman. He is the former chairman and CEO of Johnson & Johnson. Gorsky stepped down as CEO of Johnson & Johnson in January 2022 and was succeeded by Joaquin Duato. He was the seventh person who served as the company's chairman and chief executive officer since it became a publicly traded company in 1944. He is a board director of Apple and JP Morgan Chase.

<span class="mw-page-title-main">Franz Humer</span> Swiss-Austrian businessman

Franz Bernhard Humer is a Swiss-Austrian businessman, and the former chairman of Diageo, and of Roche.

John C. Lechleiter is an American businessman and chemist. He served as the President, Chief Executive Officer and Chairman of the Board of Directors of Eli Lilly and Company from April 2008 to December 2016. John Lechleiter's successor is David Ricks who assumed the role of president and CEO in January 2017. He is the eldest of nine children of Jeanne and John H. Lechleiter.

NCC Bank Limited or National Credit and Commerce Bank Limited is a Bangladeshi private commercial bank. Mr. M. Shamsul Arefin is the present Managing Director and CEO (CC) of the bank.

<span class="mw-page-title-main">Stefan Oschmann</span> German businessman (born 1957)

Stefan Oschmann is a German businessman. He was the CEO of pharma group Merck.

Joey Levin is an American businessman, currently serving as the CEO of IAC. Levin was appointed to the position in June 2015, after previously leading the company's Search & Applications segment. In October 2022, Levin was also appointed as CEO of Angi Inc.

Ramon Martin Chavez is an American investment banker and entrepreneur. He is vice chairman and partner of Sixth Street Partners. Previously, he served in a variety of senior roles at Goldman Sachs, including chief information officer (2014–2017), chief financial officer, and global co-head of the firm's Securities Division. Marty was also a partner and member of Goldman's management committee. He was the chief technology officer and co-founder of Quorum Software Systems and CEO and co-founder of Kiodex. He is chairman of the board of computational pharmaceutical company Recursion, Board Observer of biotech company Earli and longevity biopharma company Cambrian Biopharma, and board member of Alphabet Inc.

<span class="mw-page-title-main">Urs Rohner</span> Swiss lawyer, businessman and banker (born December 1, 1959)

Urs Rohner is a Swiss lawyer, businessman and banker. He is the former CEO of ProSiebenSat.1 Media and former chairman of Swiss bank Credit Suisse. After his 10 year tenure the share price lost 75% of its value leaving the bank engulfed in various scandals and subsequently apologizing for his poor performance at the last shareholder meeting. He is considered one of the worst chairmen in Swiss banking.

<span class="mw-page-title-main">Vasant Narasimhan</span> American doctor and CEO

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical Officer.

<span class="mw-page-title-main">Joaquin Duato</span> American corporate executive

Joaquin Duato is a Spanish-American business executive. Duato is a dual citizen of Spain and the United States. He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate. He is the eighth person to be CEO of Johnson & Johnson since it became a publicly-traded company in 1944.

<span class="mw-page-title-main">Thomas de Courten</span> Swiss politician

Thomas Jan de Courten is a Swiss businessman and politician. He currently serves as a member of the National Council for the Swiss People's Party (SVP) since 5 December 2011. Between 2003 and 2011, he served in the Cantonal Council of Basel-Landschaft, and as the congressional president for his party since 2007. He was also the president of the national economy and health commissions respectively.

References

  1. ↑ "Roche CEO Severin Schwan to stand down after 14 years". pharmaphorum. Retrieved 2023-04-18.
  2. ↑ Pollack, Andrew (2009-03-12). "Roche Agrees to Buy Genentech for $46.8 Billion". The New York Times. ISSN   0362-4331 . Retrieved 2023-04-18.
  3. ↑ "Impressionen & Rückblick 2019". www.tirolerwirtschaftsforum.at. Retrieved 2023-04-18.
  4. ↑ "Roche | Dr. Severin Schwan". www.roche.com. Retrieved 2023-04-18.
  5. ↑ "Minutes of Annual General Meeting" (PDF). Roche.
  6. ↑ MarketScreener. "Roche names new CEO with Schwan set to become chairman". www.marketscreener.com. Retrieved 2023-04-18.
  7. ↑ "Roche - Doing now what patients need next". www.roche.com. Retrieved 2023-04-18.
  8. ↑ "Vizepräsident nimmt den Hut - Severin Schwan verlässt Verwaltungsrat der Credit Suisse". Schweizer Radio und Fernsehen (SRF) (in German). 2022-03-21. Retrieved 2023-04-18.
  9. ↑ Keystone-SDA/Reuters/sb (21 March 2022). "Credit Suisse Vice Chair Schwan steps down from board". SWI swissinfo.ch. Retrieved 2023-04-18.{{cite web}}: |last= has generic name (help)
  10. ↑ "Roche | Dr. Severin Schwan". www.roche.com. Retrieved 2023-04-18.
  11. ↑ "Our experts". IFPMA. Retrieved 2023-04-18.
  12. ↑ "12 App Desktop". 2020-02-19. Archived from the original on 2020-02-19. Retrieved 2023-04-18.
  13. ↑ "Roche | Dr. Severin Schwan". www.roche.com. Retrieved 2023-04-18.
  14. ↑ Schaffner, Christian Dorer und Andreas (8 June 2015). "Montagsinterview - Roche-Chef Schwan: 'Misserfolg ist oft die Basis für Erfolge'". Aargauer Zeitung (in German). Retrieved 2023-04-18.
  15. ↑ "Severin Schwan: Er klingt so nett". www.zeit.de. Retrieved 2023-04-18.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.